The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2022

Filed:

May. 10, 2018
Applicants:

Emory University, Atlanta, GA (US);

University of Florida Research Foundation, Inc., Gainesville, FL (US);

Inventors:

Gary Bassell, Atlanta, GA (US);

Andrew Jenkins, Decatur, GA (US);

David B. Rye, Dunwoody, GA (US);

Maurice Scott Swanson, Gainesville, FL (US);

Eric Tzy-Shi Wang, Gainesville, FL (US);

Lyndon Lien, Hillsborough, CA (US);

Assignees:

Emory University, Atlanta, GA (US);

University of Florida Research Foundation, Inc., Gainesville, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5517 (2006.01); A61P 21/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5517 (2013.01); A61P 21/00 (2018.01);
Abstract

Disclosed are methods of treating a disorder or disease associated with myotonic dystrophy. Methods of treating a CNS dysfunction and/or cognitive impairment associated with myotonic dystrophy in a subject comprising administering a therapeutically effective amount of a GABAA receptor antagonist or inverse agonist to the subject are disclosed. Methods of treating a myotonic dystrophy associated disease or disorder caused by mis-splicing of GABRG2 in a subject comprising administering a therapeutically effective amount of a GABAA receptor antagonist or inverse agonist to the subject are disclosed. Methods of improving cognitive function or alertness in a subject having myotonic dystrophy comprising administering a therapeutically effective amount of a GABAA receptor antagonist or inverse agonist to the subject are disclosed. Examples of the GABAA receptor antagonist or inverse agonist include flumazenil, clarithromycin, a fluoroquinolone, picrotoxin, bicuculline, gabazine, cicutoxin, oenan-thotoxin, pentylenetetrazol, Ro15-4513, sarmazenil, amentoflavone, zinc, and any combination thereof.


Find Patent Forward Citations

Loading…